Iodomethane

Iodomethane

SCHEMBL8167806

CI.Cc1cccnc1C=NO

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTH P32929 3/20 0.51
FGF23 Q9GZV9 1/20 0.49
ALDH1A1 P00352 1/20 0.42
PLAU P00749 1/20 0.41
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RRM2 P31350 2/20 0.35
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
METAP2 P50579 1/20 0.34
RRM1 P23921 1/20 0.34
RRM2B Q7LG56 1/20 0.34
CISD1 Q9NZ45 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21645884 0.96 CTH (0.54) CTHFGF23ALDH1A1PLAUNOS3
SCHEMBL21645883 0.96 CTH (0.54) CTHFGF23ALDH1A1PLAUNOS3
Iodide SCHEMBL27462160 0.94 CTH (0.53) CTHFGF23ALDH1A1PLAUNOS3
SCHEMBL23420036 0.79 CTH (0.51) CTHFGF23ALDH1A1PLAUNOS3
SCHEMBL19003421 0.79 CTH (0.51) CTHFGF23ALDH1A1PLAUNOS3
SCHEMBL12287558 0.77 FGF23 (0.44) CTHFGF23ALDH1A1NPC1RAB9A
SCHEMBL25742795 0.75 CTH (0.49) CTHFGF23ALDH1A1PLAUNOS3
SCHEMBL20597363 0.75 FGF23 (0.61) CTHFGF23ALDH1A1NPC1RAB9A
SCHEMBL29402625 0.75 FGF23 (0.45) CTHFGF23ALDH1A1NPC1RAB9A
SCHEMBL16712006 0.75 FGF23 (0.45) CTHFGF23ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166032-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 2000-12-26 US claimed
US-6166032-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 2000-12-26 US disclosed
US-5981549-A Method for controlling or alleviating the symptoms of respiratory disease and allergies SYNAPSE PHARMACEUTICAL INTERNATIONAL (CA) 1999-11-09 US disclosed
US-5916903-A Method for reducing the effects of antineoplastic disease treatment SYNAPSE PAHRMACEUTICALS INTERNATIONAL, INC. (CA) 1999-06-29 US disclosed
US-5902816-A Method for treatment of heavy metal poisoning SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1999-05-11 US disclosed
US-5900418-A Method for treatment of obesity SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1999-05-04 US disclosed
US-5824684-A Method for treating drug and alcohol addiction SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-10-20 US disclosed
US-5760049-A Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use SYNAPSE PHARMACEUTICALS INTERNATIONAL, INC. (CA) 1998-06-02 US disclosed